NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
VIANAUTIS
ST13
US500000098516669Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Ben Natter Haug Partners, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in science; chemicals for encapsulating, microencapsulating and decapsulating other chemicals; chemicals for the protection, delivery, transport and triggered or controlled release of other chemicals; chemicals for encapsulating, microencapsulating and decapsulating biologically active ingredients including enzymes and cells.
Classe 5
Pharmaceutical preparations; reagents, diagnostics, prophylactics and therapeutic preparations for use in conditions of the central and peripheral nervous systems, diseases of the lung, kidney, liver or any peripheral organs, and oncology; vaccines; therapeutic preparations for use in treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, and cancer in medical and veterinary patients; targeted preparations for treating diseases of the central and peripheral nervous systems, diseases of lung, kidney, liver or other organs, or cancer; medical and veterinary preparations for use in central and peripheral nervous system diseases, diseases of the lung, kidney, liver and other organs, and cancer; medical and veterinary preparations for the delivery of compounds to the brain; medical and veterinary preparations for crossing the blood-brain barrier and other biological barriers; medical and veterinary preparations for delivering reagents, diagnostics, prophylactics and therapeutics across the blood-brain barrier and other biological barriers.
Classe 42
Scientific and technological services, namely, scientific research, analysis, testing and development in the field of delivering therapeutics, drug delivery technologies and medicines and research and design relating thereto; industrial analysis and research services in the field of therapeutics, drug delivery technologies and medicines; medical and veterinary research services; scientific research in the development of new therapies and new methods for delivering therapies; scientific research into nanoparticles; scientific research into encapsulation, microencapsulation and de-capsulation of reagents, diagnostics, prophylactics and therapeutics; scientific research into crossing the blood brain barrier and other biological barriers; scientific research into nano-engineering for intracellular delivery; consultancy relating to all the aforesaid services.
Histórico de despachos e eventos da marca no USPTO.
15 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
REGISTERED-PRINCIPAL REGISTER
22/04/2025
PUBLISHED FOR OPPOSITION
04/03/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/02/2025
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/11/2024
NON-FINAL ACTION E-MAILED
15/11/2024
NON-FINAL ACTION WRITTEN
15/11/2024
ASSIGNED TO EXAMINER
07/11/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/10/2024
NEW APPLICATION ENTERED
24/04/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.